HK1163068A1 - New water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins - Google Patents
New water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrinsInfo
- Publication number
- HK1163068A1 HK1163068A1 HK12103460.1A HK12103460A HK1163068A1 HK 1163068 A1 HK1163068 A1 HK 1163068A1 HK 12103460 A HK12103460 A HK 12103460A HK 1163068 A1 HK1163068 A1 HK 1163068A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- macrolide
- ophthalmic
- topical
- oral
- aqueous solutions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2010A001212A IT1400977B1 (it) | 2010-07-01 | 2010-07-01 | Nuovi complessi di inclusione farmaceutici, solidi, solubili in acqua e le loro soluzioni acquose per uso orale, oftalmico, topico o parenterale, contenenti un macrolide ed alcune ciclodestrine. |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1163068A1 true HK1163068A1 (en) | 2012-09-07 |
Family
ID=43034339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12103460.1A HK1163068A1 (en) | 2010-07-01 | 2012-04-10 | New water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins |
Country Status (8)
Country | Link |
---|---|
US (1) | US9169269B2 (hu) |
EP (1) | EP2402350B1 (hu) |
JP (1) | JP5856769B2 (hu) |
BR (1) | BRPI1103562A2 (hu) |
ES (1) | ES2534989T3 (hu) |
HK (1) | HK1163068A1 (hu) |
HU (1) | HUE025154T2 (hu) |
IT (1) | IT1400977B1 (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014117035A1 (en) | 2013-01-24 | 2014-07-31 | Transderm, Inc. | COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS |
HUP1400075A2 (hu) | 2014-02-14 | 2015-08-28 | Druggability Technologies Ip Holdco Jersey Ltd | Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói |
WO2018129364A1 (en) | 2017-01-06 | 2018-07-12 | Palvella Therapeutics Llc | Anhydrous compositions of mtor inhibitors and methods of use |
JP7376361B2 (ja) | 2017-03-07 | 2023-11-08 | エフ. ホフマン-ラ ロシュ アーゲー | 免疫調節マクロライドのための安定な配合物 |
CN107213470B (zh) * | 2017-06-01 | 2020-05-19 | 中牧南京动物药业有限公司 | 酒石酸泰万菌素可溶性粉及其制备方法 |
US11000513B2 (en) | 2018-07-02 | 2021-05-11 | Palvella Therapeutics, Inc. | Anhydrous compositions of mTOR inhibitors and methods of use |
WO2023213731A1 (en) | 2022-05-02 | 2023-11-09 | Roche Diagnostics Gmbh | Hemolysis and derivatization reagents and methods for determining lactone analytes |
WO2024074699A1 (en) | 2022-10-07 | 2024-04-11 | Oculis Operations Sarl | Eye drop microsuspensions of mtor inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002935A (en) | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
BE1009856A5 (fr) * | 1995-07-14 | 1997-10-07 | Sandoz Sa | Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule. |
US7655442B2 (en) * | 2004-01-29 | 2010-02-02 | Eisai R&D Management Co., Ltd. | Method for stabilizing macrolide compounds |
DE602005024012D1 (de) | 2004-08-27 | 2010-11-18 | Cordis Corp | Lösungsmittelfreies amorphes rapamycin |
US20060094744A1 (en) | 2004-09-29 | 2006-05-04 | Maryanoff Cynthia A | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
EP2135601A1 (en) * | 2008-06-20 | 2009-12-23 | Capsulution Nanoscience AG | Stabilization of amorphous drugs using sponge-like carrier matrices |
-
2010
- 2010-07-01 IT ITMI2010A001212A patent/IT1400977B1/it active
-
2011
- 2011-06-16 ES ES11170078.7T patent/ES2534989T3/es active Active
- 2011-06-16 HU HUE11170078A patent/HUE025154T2/hu unknown
- 2011-06-16 EP EP11170078.7A patent/EP2402350B1/en active Active
- 2011-06-29 US US13/172,038 patent/US9169269B2/en active Active
- 2011-06-30 JP JP2011145736A patent/JP5856769B2/ja active Active
- 2011-07-01 BR BRPI1103562-5A patent/BRPI1103562A2/pt not_active IP Right Cessation
-
2012
- 2012-04-10 HK HK12103460.1A patent/HK1163068A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2402350A1 (en) | 2012-01-04 |
JP5856769B2 (ja) | 2016-02-10 |
ES2534989T3 (es) | 2015-05-04 |
BRPI1103562A2 (pt) | 2015-07-28 |
JP2012031160A (ja) | 2012-02-16 |
ITMI20101212A1 (it) | 2012-01-02 |
IT1400977B1 (it) | 2013-07-05 |
US20120053198A1 (en) | 2012-03-01 |
HUE025154T2 (hu) | 2016-03-29 |
EP2402350B1 (en) | 2015-01-28 |
US9169269B2 (en) | 2015-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1163068A1 (en) | New water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins | |
NL301021I1 (nl) | talazoparib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout. | |
NL300909I2 (nl) | Ribociclib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout | |
AP2010005490A0 (en) | Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin. | |
NL300971I2 (nl) | Eravacycline, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout | |
HRP20160953T1 (hr) | Vodeni farmaceutski sastavi koji sadrže komplekse borat-poliol | |
EP2604612A4 (en) | C-ARYL-GLUCOSIDE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | |
HK1161878A1 (en) | Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof | |
IL222930A0 (en) | Chlorotoxin variants, conjugates and methods for their use | |
IL214175A (en) | Derivatives of aminotetralin, their pharmaceutical compositions and their use | |
HK1145631A1 (en) | Aqueous pharmaceutical compositions containing borate-polyol complexes | |
IL225227B (en) | A complex containing cyclodextrin and fulvestrant, its uses and methods for its preparation | |
EP2763693A4 (en) | BLOOD CREATION FACTOR AND DERIVATIVES, CONJUGATES AND COMPLEXES THEREOF AND USE THEREOF | |
EP2510825B8 (en) | Rotary draw bar | |
WO2012131378A3 (en) | Pharmaceutical preparation comprising alpha emitting radionuclide | |
HK1249848A1 (zh) | 親脂性物質的水溶液,特別是藥物物質溶液 | |
PL2480540T3 (pl) | Pentahydrat chlorku metylotioninowego, jego wytwarzanie i zastosowanie farmaceutyczne | |
EP2331555B8 (fr) | Dérives ferroceniques a activite anticancereuse |